Real-world evidence on fremanezumab for migraine treatment in Japan: a retrospective analysis

被引：0
|
作者：
Takizawa, T. [1 ]
Ohtani, S. [1 ,2 ]
Watanabe, N. [1 ]
Ihara, K. [1 ]
Takahashi, N. [1 ]
Miyazaki, N. [3 ]
Ishizuchi, K. [1 ]
Takemura, R. [3 ]
Hori, S. [2 ]
Nakahara, J. [1 ]
机构：
[1] Keio Univ, Sch Med, Dept Neurol, Tokyo, Japan
[2] Keio Univ, Fac Pharm, Div Drug Informat, Tokyo, Japan
[3] Keio Univ Hosp, Biostat Unit, Clin & Translat Res Ctr, Tokyo, Japan
来源：
JOURNAL OF HEADACHE AND PAIN | 2024年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P254
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine
    Driessen, Maurice T.
    Cohen, Joshua M.
    Thompson, Stephen F.
    Patterson-Lomba, Oscar
    Seminerio, Michael J.
    Carr, Karen
    Totev, Todor, I
    Sun, Rochelle
    Yim, Erica
    Mu, Fan
    Ayyagari, Rajeev
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01):
  • [22] TREATMENT OF PSORIASIS: ANALYSIS OF REAL-WORLD EVIDENCE
    Karbusicka, M.
    Duba, J.
    Kolek, M.
    VALUE IN HEALTH, 2019, 22 : S911 - S912
  • [23] Real-world Reductions in Migraine and Headache Days for Patients With Chronic and Episodic Migraine Initiating Fremanezumab in the US
    Cohen, Joshua M.
    Thompson, Stephen
    Patterson-Lomba, Oscar
    Driessen, Maurice
    Seminerio, Michael
    Carr, Karen
    Mu, Fan
    NEUROLOGY, 2021, 96 (15)
  • [24] TREATMENT PATTERNS IN MIGRAINE: A REAL-WORLD ANALYSIS IN A US POPULATION
    Lombard, L.
    Ford, J.
    Jackson, J.
    Milligan, G.
    Cotton, S.
    Ahl, J.
    CEPHALALGIA, 2016, 36 : 29 - 30
  • [25] Real-world patient characteristics, acute medication use, and treatment patterns for patients initiating fremanezumab treatment: A US retrospective claims analysis
    Buse, D. C.
    Seminerio, M. J.
    Thompson, S. F.
    Cohen, J. M.
    Tangirala, K.
    Ariely, R.
    Rubin, A.
    Carr, K.
    HEADACHE, 2021, 61 : 72 - 73
  • [26] Real-World Retrospective Safety Analysis of OnabotulinumtoxinA for the Treatment of Patients with Concurrent Cervical Dystonia and Chronic Migraine
    Rhyne, C.
    Martinez, K.
    Stoilova, J.
    Patel, A.
    Ifantides, K. Becker
    Singh, R.
    Yushmanova, I.
    Sadeghi, M.
    Battucci, S.
    Forde, G.
    MOVEMENT DISORDERS, 2023, 38 : S350 - S351
  • [27] Real-world Retrospective Safety Analysis of OnabotulinumtoxinA for the Treatment of Patients With Concurrent Cervical Dystonia and Chronic Migraine
    Rhyne, Christopher
    Martinez, Kenneth
    Stoilova, Juliana
    Patel, Atul
    Ifantides, Kim Becker
    Singh, Ritu
    Yushmanova, Irina
    Sadeghi, Marjan
    Battucci, Simona
    Grace, Forde
    TOXICON, 2024, 237 : 73 - 74
  • [28] Efficacy of fremanezumab in refractory chronic migraine patients: Real-world data from the Hull Migraine Clinic, UK
    Cheng, F.
    Hussain, M.
    Wilkinson, V.
    Khalil, M.
    Ahmed, F.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 2):
  • [29] Real-world treatment chronic migraine in Poland
    Domitrz, Izabela
    Karaszewski, Bartosz
    Stepien, Adam
    ARCHIVES OF MEDICAL SCIENCE, 2024, 20 (06) : 2082 - 2084
  • [30] Efficacy of fremanezumab in refractory chronic migraine patients: Real-world data from the Hull Migraine Clinic, UK
    Cheng, F.
    Hussain, M.
    Wilkinson, V.
    Khalil, M.
    Ahmed, F.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 262 - 262
12345